Are provisional applications required to comply with sequence listing requirements?

According to MPEP 2422.07, provisional applications are not required to comply with sequence listing requirements: “Provisional applications filed under 35 U.S.C. 111(b) need not comply with 37 CFR 1.821 through 1.825, however, applicants are encouraged to file a “Sequence Listing” as defined in 37 CFR 1.821(c) for ease of identification of the sequence information contained…

Read More

What are the requirements for submitting a “Sequence Listing” in a patent application?

According to MPEP 2427, patent applications containing nucleotide and/or amino acid sequence disclosures must include a “Sequence Listing” as a separate part of the disclosure. This can be submitted in several ways: As an ASCII text file via the USPTO’s electronic filing system On read-only optical discs As a PDF file via EFS-Web or Patent…

Read More

What are the requirements for submitting sequence listings in international applications?

For international applications, MPEP 2422.07 outlines specific requirements for submitting sequence listings: “Where a sequence listing under PCT Rule 13ter is provided in reply to a under 37 CFR 1.821(h) , the sequence listing must be accompanied by a statement that the information recorded in the ASCII plain text file under 37 CFR 1.821(e)(3)(i) is…

Read More

What changes have been made to the “Sequence Listing” requirements for applications filed on or after July 1, 2022?

For patent applications filed on or after July 1, 2022, there have been significant changes to the “Sequence Listing” requirements. The MPEP section 2424.01 includes an important editor’s note: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined…

Read More

When did the requirements for Sequence Listings change?

The requirements for Sequence Listings in patent applications changed on July 1, 2022. This is clearly stated in the MPEP: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” For applications filed before July…

Read More

Do the “Sequence Listing” Numeric Identifier requirements apply to all patent applications?

No, the “Sequence Listing” Numeric Identifier requirements do not apply to all patent applications. The MPEP 2424.02 includes an important note: “This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP ยงยง 2412 – 2419…

Read More

What are the requirements for submitting a “Sequence Listing” as a PDF file or on physical sheets of paper?

When submitting a “Sequence Listing” as a PDF file or on physical sheets of paper, the following requirements apply: The “Sequence Listing” must be placed after the abstract of the disclosure A separate CRF under 37 CFR 1.821(e) is required If the separate CRF was not submitted, not compliant with 37 CFR 1.824, or not…

Read More